April 28, 2016
2016 FIRST QUARTER
BOIRON ACTIVITY
(Unaudited data)
in thousands of euros 2015 2016 Variation at
current
exchange rates
Variation at
constant
exchange
rates
France 89,584 90,494 +1.0% +1.0%
Europe (excluding France) 40,657 43,685 +7.4% +12.5%
North America 17,193 16,064 -6.6% -7.3%
Other countries 4,622 3,846 -16.8% -13.0%
Group total 152,056 154,089 +1.3% +2.7%
in thousands of euros 2015 2016 Variation at
current
exchange rates
Variation at
constant
exchange
rates
Non-proprietary Homeopathic Medicines 79,191 80,147 +1.2% +1.2%
OTC Specialties 72,880 73,743 +1.2% +4.1%
Other -15 199 - -
Group total 152,056 154,089 +1.3% +2.7%
HIGHLIGHTS OF THE FIRST QUARTER
Sales in the first quarter of 2016 rose by 1.3% compared to the first quarter of 2015 (+2.7% at
constant rate).
Our Company continues with the same passion the development of homeopathy in the world.
For the current year, we remain cautious on the development of sales and result.
Our next updates:
May 19, 2016 at 10:30 am, at BOIRON headquarters, 2 avenue de l'Ouest Lyonnais, 69510 MESSIMY - FRANCE: Ordinary
Shareholders' Meeting.
June 3, 2016: after approval by the Ordinary Shareholders' Meeting, payment of the proposed dividend (€1.50 per share).
July 19, 2016: after the close of the stock market, publication of the sales on June 30, 2016.
Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail : boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at: www.boironfinance.com

Boiron SA issued this content on 28 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 28 April 2016 23:23:42 UTC